CATX

Perspective Therapeutics Inc

5.00

-0.11-2.15%

After Hours: 4.999 -0.001 -0.02%19:44 03/13 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE5.12/5.11

TODAY RANGE4.875-5.24

VOL1.09M

MARKET CAP569.57M

52 WEEK RANGE1.600-6.16

AVG VOL (3M)3.37M

% TURNOVER0.96%

TURNOVER--

P/E (TTM)-3.4310

% RANGE7.14%

EPS(TTM)-1.4573

P/E(FORWARD)-3.9526

P/B1.535

BVPS3.258

DIVIDEND--

P/S242.72

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP502.30M

SHARES OUTSTANDING113.91M

NEXT EARNINGS04/27-05/12

FREE FLOAT100.46M

LOT SIZE1

EX-DATE06/17/2024

News

Press Releases

Financial Reports

Profile

Seeking Alpha·2d ago
Perspective Therapeutics Q4 2025 Earnings Preview
TipRanks·4d ago
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks·03/06 12:40
Analysts Offer Insights on Healthcare Companies: Perspective Therapeutics (CATX), ArriVent BioPharma, Inc. (AVBP) and Evommune, Inc. (EVMN)
Dow Jones·02/19 11:31
Perspective Therapeutics Price Target Announced at $16.00/Share by Piper Sandler
Dow Jones·02/19 11:31
Perspective Therapeutics Initiated at Overweight by Piper Sandler
TipRanks·02/19 10:15
Perspective Therapeutics initiated with an Overweight at Piper Sandler
TipRanks·02/19 01:50
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks·02/18 14:15
Perspective Therapeutics (CATX) Receives a Buy from JonesTrading
TipRanks·02/17 06:45
Buy Rating on Perspective Therapeutics (CATX) Driven by Differentiated Radiopharmaceutical Platform and Undervalued Long-Term Upside
TipRanks·02/12 16:00
Analysts Offer Insights on Healthcare Companies: Harrow Health (HROW), Icon (ICLR) and Perspective Therapeutics (CATX)
TipRanks·02/03 21:36
Perspective Therapeutics Raises Capital to Advance Radiopharmaceutical Pipeline
NASDAQ·02/03 06:53
Perspective Therapeutics Prices Approx. $175 Mln Offering Of Shares And Pre-Funded Warrants
TipRanks·02/02 17:06
Midday Fly By: Disney slips despite Q1 beat, Devon to combine with Coterra
Dow Jones·02/02 15:57
Perspective Therapeutics Rises on $175M Stock Offering
TipRanks·02/02 13:46
Perspective Therapeutics prices 39.58M shares at $3.79 in underwritten offering

Same Industry

Name/Symbol

Change%

Price

Perspective Therapeutics Inc

CATX

-2.15%

5.00

Regeneron Pharmaceuticals

REGN

-0.11%

745.77

GRDX

BIONTECH

BNTX

+1.21%

91.19

United Therapeutics Corp.

UTHR

+0.62%

536.12

Vertex Pharmaceuticals Inc

VRTX

-1.84%

469.34

Siga Technologie

SIGA

-3.84%

5.26

Moderna

MRNA

-1.55%

52.56

CRL

MEDP

TLPH

ICLR

CBPO

IQV

MOLECULAR PARTNERS AG

MOLN

-10.40%

4.220

ARCT

GILD

PRA Health

PRAH

0.00%

165.21

INCY

Aptevo Therapeutics Inc

APVO

-3.28%

4.420

BSTC

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.